Compared to patients with metabolically unhealthy obesity, individuals with MHO are distinguished by lower liver and visceral fat but higher subcutaneous leg fat content, higher cardiorespiratory fitness and physical activity, insulin sensitivity, lower levels of inflammatory markers, and normal adipose tissue function [6]. The gene discussed is INS; the disease is obesity disorder.